A Dermal Equivalent Engineered with TGF-β3 Expressing Bone Marrow Stromal Cells and Amniotic Membrane: Cosmetic Healing of Full-Thickness Skin Wounds in Rats

被引:21
作者
Samadikuchaksaraei, Ali [1 ,2 ,3 ]
Mehdipour, Ahmad [2 ]
Roudkenar, Mehryar Habibi [4 ]
Verdi, Javad [5 ]
Joghataei, Mohammad Taghi [1 ]
As'adi, Kamran [6 ]
Amiri, Fatemeh [4 ]
Harati, Mozhgan Dehghan [7 ]
Gholipourmalekabadi, Mazaher [1 ,2 ,8 ]
Osguei, Nushin Karkuki [9 ]
机构
[1] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran
[2] Iran Univ Med Sci, Dept Tissue Engn & Regenerat Med, Fac Adv Technol Med, Tehran, Iran
[3] Iran Univ Med Sci, Fac Allied Med, Dept Med Biotechnol, Tehran, Iran
[4] Guilan Univ Med Sci, Fac Allied Med, Dept Med Biotechnol, Rasht, Iran
[5] Univ Tehran Med Sci, Fac Adv Technol Med, Dept Appl Cellular Sci, Tehran, Iran
[6] Iran Univ Med Sci, Fac Med, Dept Plast & Reconstruct Surg, Tehran, Iran
[7] Univ Hosp Tuebingen, Translat Oncol, Dept Hematol Oncol Immunol Rheumatol & Pulmonol, Tubingen, Germany
[8] Shahid Beheshti Univ Med Sci, Fac Med, Dept Med Biotechnol, Tehran, Iran
[9] Eposcience Millennium Inst, Tehran, Iran
基金
美国国家科学基金会;
关键词
Cicatrix; Keloid; Re-epithelialization; Scar; Transforming growth factor beta-3; MESENCHYMAL STEM-CELLS; HYPERTROPHIC SCAR FORMATION; FACTOR-BETA; 3; GROWTH-FACTOR; TGF-BETA; GENE DELIVERY; IN-VITRO; PROLIFERATION; AVOTERMIN; SCAFFOLD;
D O I
10.1111/aor.12807
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Transforming growth factor beta-3 (TGF-beta 3) has been shown to decrease scar formation after scheduled topical applications to the cutaneous wounds. This study aimed to continuously deliver TGF-beta 3, during the early phase of wound healing, by engineering a dermal equivalent (DE) using TGF-beta 3 expressing bone marrow stromal cells (BM-SCs) and human dehydrated amniotic membrane (hDAM). To engineer a DE, rat BM-SCs were seeded on the hDAM and TGF-beta 3 was transiently transfected into the BM-SCs using a plasmid vector. Pieces of the dermal equivalent were transplanted onto the full-thickness excisional skin wounds in rats. The process of wound healing was assessed by image analysis, Manchester Scar Scale (MSS), and histopathological studies 7, 14, 21, and 85 days after the excision. The results confirmed accurate construction of recombinant pcDNA3.1-TGF-beta 3 expression system and showed that the transfected BM-SCs seeded on hDAM expressed TGF-beta 3 mRNA and protein from day 3 through day 7 after transfection. After implantation of the DE, contraction of the wounds was measured from day 7 through 21 and analyzed by linear regression, which revealed that the rate of wound contraction in all experimental groups was similar. Histologic evaluation demonstrated that transfected BM-SCs decreased retention and recruitment of the cells during the early stage of wound healing, decreased the formation of vascular structures and led to formation of uniformly parallel collagen bundles. MSS scores showed that TGF-beta 3 secreting cells significantly improved the cosmetic appearance of the healed skin and decreased the scar formation. From these results, it could be concluded that transient secretion of TGF-beta 3, during the early phase of healing, by BM-SCs seeded on hDAM can improve the cosmetic appearance of the scar in cutaneous wounds without negatively affecting the process of wound repair.
引用
收藏
页码:E266 / E279
页数:14
相关论文
共 54 条
  • [1] Human mesenchymal stem cells modulate allogeneic immune cell responses
    Aggarwal, S
    Pittenger, MF
    [J]. BLOOD, 2005, 105 (04) : 1815 - 1822
  • [2] Cellular and molecular pathology of HTS: basis for treatment
    Armour, Alexis
    Scott, Paul G.
    Tredget, Edward E.
    [J]. WOUND REPAIR AND REGENERATION, 2007, 15 : S6 - S17
  • [3] A "traffic control" role for TGFβ3:: orchestrating dermal and epidermal cell motility during wound healing
    Bandyopadhyay, B
    Fan, JH
    Guan, SX
    Li, Y
    Chen, M
    Woodley, DT
    Li, W
    [J]. JOURNAL OF CELL BIOLOGY, 2006, 172 (07) : 1093 - 1105
  • [4] A new quantitative scale for clinical scar assessment
    Beausang, E
    Floyd, H
    Dunn, KW
    Orton, CI
    Ferguson, MWJ
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1998, 102 (06) : 1954 - 1961
  • [5] Fibroblast growth factor-2 promotes healing of surgically created periodontal defects in rats with early, streptozotocin-induced diabetes via increasing cell proliferation and regulating angiogenesis
    Bizenjima, Takahiro
    Seshima, Fumi
    Ishizuka, Yoichi
    Takeuchi, Takahiro
    Kinumatsu, Takashi
    Saito, Atsushi
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2015, 42 (01) : 62 - 71
  • [6] MicroRNA Profiling in Mid- and Late-Gestational Fetal Skin: Implication for Scarless Wound Healing
    Cheng, Jie
    Yu, Hongbo
    Deng, Simin
    Shen, Guofang
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 221 (03) : 203 - 209
  • [7] Bevacizumab: A potential agent for prevention and treatment of hypertrophic scar
    Diao, Jian-Sheng
    Xia, Wen-Sen
    Guo, Shu-Zhong
    [J]. BURNS, 2010, 36 (07) : 1136 - 1137
  • [8] Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers
    Drinkwater, SL
    Burnand, KG
    Ding, R
    Smith, A
    [J]. JOURNAL OF VASCULAR SURGERY, 2003, 38 (05) : 1106 - 1112
  • [9] Fearmonti Regina, 2010, Eplasty, V10, pe43
  • [10] Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies
    Ferguson, Mark W. J.
    Duncan, Jonathan
    Bond, Jeremy
    Bush, James
    Durani, Piyush
    So, Karen
    Taylor, Lisa
    Chantrey, Jonquille
    Mason, Tracey
    James, Gaynor
    Laverty, Hugh
    Occleston, Nick L.
    Sattar, Abdul
    Ludlow, Anna
    O'Kane, Sharon
    [J]. LANCET, 2009, 373 (9671) : 1264 - 1274